The previous studies of our group have demonstrated a coactivating relationship between FSTL3 and the BMP/SMAD signaling, showing that it can regulate the SMAD phosphorylation and promote EMT in gastric cancer cells (Liu et al., 2021). This evidence concerns the gene FSTL3 and gastric cancer.